Loading the news
[ Signal feed // AI news ]
913 articles
Pharmaceutical giant AstraZeneca has entered into an AI partnership worth up to $1.5 billion with biotech firm insitro. The collaboration focuses on leveraging artificial intelligence for MASH and cardiovascular research.
Relevance: 3 / 5
Open the original article in a new tabThis commentary analyzes the traceability of data generated by artificial intelligence in enterprise environments. It emphasizes that companies must preserve the background and sources of AI responses to ensure authenticity.
Relevance: 4 / 5
Open the original article in a new tabAccording to the article, new artificial intelligence labs are raising massive amounts of money from investors. However, many of them currently have little tangible results to show for it.
Relevance: 3 / 5
Open the original article in a new tabSpecialty1 Partners is investing in artificial intelligence to improve specialty dental care. The technology aims to enhance clinical workflows and patient care.
Relevance: 3 / 5
Open the original article in a new tabSpecialty1 Partners is investing in artificial intelligence to shape the future of specialty dental care. The technology aims to improve healthcare services.
Relevance: 3 / 5
Open the original article in a new tabThe ERGO Group has appointed Guy Goldstein as its Chief Artificial Intelligence Officer. The move is designed to strengthen the company's AI strategy.
Relevance: 3 / 5
Open the original article in a new tabThe article details how Lockheed Martin integrated artificial intelligence into its human resources processes. The focus is on building secure and scalable solutions.
Relevance: 3 / 5
Open the original article in a new tabAstraZeneca formed another significant partnership with insitro. The agreement aims to accelerate artificial intelligence-driven drug development.
Relevance: 3 / 5
Open the original article in a new tabThe article examines how artificial intelligence is transforming the online presence of law firms. Methods for client visibility are continuously evolving.
Relevance: 3 / 5
Open the original article in a new tabPharmaceutical company AstraZeneca signed a major deal with insitro. The partnership focuses on AI-enabled drug discovery for various diseases.
Relevance: 3 / 5
Open the original article in a new tabAccording to World Economic Forum analysis, artificial intelligence enables faster work, but this does not automatically mean a return on investment. Companies often forget to adapt their processes to new technologies. As a result, productivity growth may fall short of expectations.
Relevance: 3 / 5
Open the original article in a new tab